Trial Profile
Multicenter phase Ib-II dose-escalation of trabectedin (Yondelis) in combination with oxaliplatin in patients with cancer pretreated advanced ovarian. [Étude multicentrique de phase Ib-II en escalade de dose de la trabectédine (Yondelis) en association avec l'oxaliplatine chez des patientes atteintes d'un cancer de l'ovaire avancé prétraité.]
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 28 Jul 2012
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Trabectedin (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors PharmaMar
- 14 Jun 2011 New trial record